Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Cabozantinib is a multi-targeted tyrosine kinase inhibitor that plays an important role in the treatment of a variety of diseases.What diseases is cabozozantinib suitable for?Cabob···【more】
Article source：Captain MedicineRelease date：2025-02-13Recommended：320
Cabotinib is a multi-targeted tyrosine kinase inhibitor that has shown broad potential for use in the medical field.What are the indications for cabozantinibCabozozantinib is appro···【more】
Article source：Captain MedicineRelease date：2025-02-13Recommended：357
Cabozantinib is an important anti-tumor drug, and its price has always been the focus of attention for patients and the medical community.Is cabozantinib expensive? How much is a b···【more】
Article source：Captain MedicineRelease date：2025-02-12Recommended：301
Cabozantinib is an important targeted therapy drug, and its price dynamics have been of great concern to patients and the medical community.Cabozantinib latest price in 2025With th···【more】
Article source：Captain MedicineRelease date：2025-02-12Recommended：323
As a multi-targeted tyrosine kinase inhibitor, cabozantinib has shown broad application potential in the treatment of tumors.How much is cabozantinib per boxExplore the price of ca···【more】
Article source：Captain MedicineRelease date：2025-02-11Recommended：342
The interaction of avatrombopag with other drugs in clinical application has attracted much attention.How avatrombopag interacts with other medicationsExploring the interaction bet···【more】
Article source：Captain MedicineRelease date：2025-02-11Recommended：274
Avatrombopag is a thrombopoietic drug that is widely used in the treatment of thrombocytopenia. However, its interaction with other drugs has always been a focus of concern for doc···【more】
Article source：Captain MedicineRelease date：2025-02-10Recommended：291
Avatrombopag is a novel thrombopoietin receptor agonist, which has attracted much attention in clinical application, and its drug interaction has become a common concern for doctor···【more】
Article source：Captain MedicineRelease date：2025-02-10Recommended：291
Avatrombopag, as a thrombopoietin receptor agonist, plays an important role in the treatment of thrombocytopenia. However, there are certain precautions to be taken with respect to···【more】
Article source：Captain MedicineRelease date：2025-02-07Recommended：380
Avatrombopag is an important platelet-stimulating drug, and special care should be taken when using it to ensure its safety and efficacy.What are the precautions for avatrombopagIt···【more】
Article source：Captain MedicineRelease date：2025-02-07Recommended：432
Avatrombopag is an innovative drug that has shown significant results in the treatment of thrombocytopenia, but the precautions during its use are equally important.What are the pr···【more】
Article source：Captain MedicineRelease date：2025-02-06Recommended：305
Avatrombopag is a novel thrombopoietin receptor agonist, and its safety and side effects have attracted much attention.Does avatrombopag have side effectsTo explore the possible si···【more】
Article source：Captain MedicineRelease date：2025-02-06Recommended：338
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：4472025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：6362024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended：902026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：4142025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：4332025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：4182025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：4742025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3852025-01-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
